How CardMedic CEO Dr Rachael Grimaldi Launched A Language-Driven Healthcare Startup In Just 72 Hours

Dr Rachael Grimaldi, CEO and Co-founder of CardMedic, talks about how one idea has helped hundreds of healthcare workers communicate more efficiently with patients. Read the full article here.

Read more: How CardMedic CEO...

AI should come with green, yellow, and red lights for mental health

Mental health treatment is expensive and hard to find, so it’s no surprise that people looking for empathy and care are turning to large language models like ChatGPT and Claude. Researchers are exploring and validating tailored artificial intelligence solutions to deliver evidence-based psychotherapies.  Read more…

Read more: AI should come wi...

AI stethoscope could detect major heart conditions in seconds

Stethoscopes powered by artificial intelligence (AI) could help detect three different heart conditions in seconds, researchers say. Read more here.

Read more: AI stethoscope co...

AI Speech Model Detects Neurological Disorders With 92% Accuracy

A new AI framework can detect neurological disorders by analyzing speech with over 90% accuracy. The model, called CTCAIT, captures subtle patterns in voice that may indicate early symptoms of diseases like Parkinson’s, Huntington’s, and Wilson disease. Read more here.

Read more: AI Speech Model D...

Google Translate is using AI to help users learn languages

Google is using Gemini AI to increase the power of Google Translate. Now, Translate allows users to practice new languages by creating personalized listening and speaking practice sessions in their preferred language. Read more here.

Read more: Google Translate ...

Study identifies molecular pathway that drives advanced prostate cancer

University of Kentucky Markey Cancer Center researchers have identified a cellular pathway that fuels the progression of aggressive, drug-resistant prostate cancer.  Read more here.

Read more: Study identifies ...

Akeso says its closely watched drug improved patient survival in a lung cancer trial

Akeso, a Chinese biotech with a drug positioned to rival Merck’s megablockbuster Keytruda, has reported for the first time that the therapy can improve patient survival. Read more here.

Read more: Akeso says its cl...

Tempus AI acquires Paige for $81M

AI-powered data company Tempus AI announced it will acquire Paige, an AI-enabled diagnostic platform for oncologists and pathologists, for $81.25 million. Read more here.

Read more: Tempus AI acquire...

Waystar makes $1.25B bet on AI for healthcare payments

Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities. Read more here.

Read more: Waystar makes $1....

NICE approves new treatment for inflammatory bowel disease

Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS. Read more here.

Read more: NICE approves new...

Scientists discover eight new schizophrenia genes

The breakthrough, made by scientists at the Centre for Neuropsychiatric Genetics and Genomics (CNGG) at Cardiff University, provides new information and improves the understanding and future treatment development for schizophrenia. Read more here.  

Read more: Scientists discov...

Quarter of junior doctors work part-time

In a survey of 50,000 junior doctors, now officially known as resident doctors, 24 per cent said they opted to work “less than full-time”. The average full-time hours are 40 to 48 hours per week. Read more here.

Read more: Quarter of junior...